107 related articles for article (PubMed ID: 19306543)
21. Hereditary breast and ovarian cancer syndrome and issues in pediatric and adolescent practice.
Herman JD; Appelbaum H
J Pediatr Adolesc Gynecol; 2010 Aug; 23(4):253-8. PubMed ID: 20632459
[No Abstract] [Full Text] [Related]
22. No association of miscarriage and BRCA carrier status in Pakistani breast/ovarian cancer patients with a history of parental consanguinity.
Rashid MU; Torres D; Rasheed F; Sultan F; Shakoori AR; Amin A; Schlaefer K; Hamann U
Breast Cancer Res Treat; 2009 Jul; 116(1):211-3. PubMed ID: 18574689
[No Abstract] [Full Text] [Related]
23. Hereditary breast and ovarian cancer: risks and challenges. 10-12 September 2009: Bari, Italy. Introduction.
Paradiso A; Muggia F
Ann Oncol; 2011 Jan; 22 Suppl 1():i5-6. PubMed ID: 21285151
[No Abstract] [Full Text] [Related]
24. Hereditary breast and ovarian cancer: risks and challenges. Proceedings of a meeting. September 10-12, 2009. Bari, Italy.
Ann Oncol; 2011 Jan; 22 Suppl 1():i5-68. PubMed ID: 21438196
[No Abstract] [Full Text] [Related]
25. Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.
Evans DG; Lalloo F; Ashcroft L; Shenton A; Clancy T; Baildam AD; Brain A; Hopwood P; Howell A
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2318-24. PubMed ID: 19661091
[TBL] [Abstract][Full Text] [Related]
26. Genetic counseling and the advanced practice oncology nursing role in a hereditary cancer prevention clinic: hereditary breast cancer focus (part II).
Lynch HT; Snyder CL; Lynch JF
Breast J; 2009; 15 Suppl 1():S11-9. PubMed ID: 19775324
[TBL] [Abstract][Full Text] [Related]
27. Genetic counseling about reproductive options for hereditary cancer: what is the standard of care?
Peshkin BN; Nusbaum RH; DeMarco TA
J Clin Oncol; 2007 Mar; 25(7):911-2; author reply 913. PubMed ID: 17327618
[No Abstract] [Full Text] [Related]
28. The clinical implications of genetics. BRCA1- and BRCA2-positive: how do I proceed? Implications for ovarian cancer prevention.
Verheijen RH; Hermsen B
Ann Oncol; 2008 Jul; 19 Suppl 5():v84-6. PubMed ID: 18611907
[No Abstract] [Full Text] [Related]
29. Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.
Vadaparampil ST; Quinn GP; Miree CA; Brzosowicz J; Carter B; Laronga C
Ann Surg Oncol; 2009 Jul; 16(7):1973-81. PubMed ID: 19408048
[TBL] [Abstract][Full Text] [Related]
30. Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers.
Matloff ET; Barnett RE; Bober SL
Cancer J; 2009; 15(1):15-8. PubMed ID: 19197168
[TBL] [Abstract][Full Text] [Related]
31. [Cancer genetics: estimation of the needs of the population in France for the next ten years].
Bonaïti-Pellié C; Andrieu N; Arveux P; Bonadona V; Buecher B; Delpech M; Jolly D; Julian-Reynier C; Luporsi E; Noguès C; Nowak F; Olschwang S; Orsi F; Pujol P; Saurin JC; Sinilnikova O; Stoppa-Lyonnet D; Thépot F
Bull Cancer; 2009 Sep; 96(9):875-900. PubMed ID: 19751997
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer prevention in BRCA1/2 mutation carriers: a qualitative review.
Fuller S; Liebens F; Carly B; Pastijn A; Rozenberg S
Breast J; 2008; 14(6):603-4. PubMed ID: 19054005
[No Abstract] [Full Text] [Related]
33. Socio-demographic and clinical profile of BRCA1/2 mutation carriers opting for prophylactic oophorectomy.
Dagan E; Gil S; Gershoni-Baruch R
Prev Med; 2008 May; 46(5):470-2. PubMed ID: 18255133
[No Abstract] [Full Text] [Related]
34. Genetic counseling for familial cancer risk.
Weitzel JN
Hosp Pract (1995); 1996 Feb; 31(2):57-69. PubMed ID: 8592019
[TBL] [Abstract][Full Text] [Related]
35. Unclassified variants in disease-causing genes: nonuniformity of genetic testing and counselling, a proposal for guidelines.
Vink GR; van Asperen CJ; Devilee P; Breuning MH; Bakker E
Eur J Hum Genet; 2005 May; 13(5):525-7. PubMed ID: 15741995
[No Abstract] [Full Text] [Related]
36. Genetic counseling and the advanced practice oncology nursing role in a hereditary cancer prevention clinic: hereditary breast cancer focus (part I).
Snyder CL; Lynch JF; Lynch HT
Breast J; 2009; 15 Suppl 1():S2-10. PubMed ID: 19775325
[TBL] [Abstract][Full Text] [Related]
37. ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy.
ACOG
Obstet Gynecol; 2008 Jan; 111(1):231-41. PubMed ID: 18165419
[No Abstract] [Full Text] [Related]
38. Commentary: patient counseling and education.
Mahon SM
Oncol Nurs Forum; 1997 May; 24(4):635-6. PubMed ID: 9159774
[No Abstract] [Full Text] [Related]
39. Mammary tumor development in dogs is associated with BRCA1 and BRCA2.
Rivera P; Melin M; Biagi T; Fall T; Häggström J; Lindblad-Toh K; von Euler H
Cancer Res; 2009 Nov; 69(22):8770-4. PubMed ID: 19887619
[TBL] [Abstract][Full Text] [Related]
40. Controversies in communication of genetic risk for hereditary breast cancer.
Mackenzie A; Patrick-Miller L; Bradbury AR
Breast J; 2009; 15 Suppl 1():S25-32. PubMed ID: 19775327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
